Get started
Author

Crispin Lumbala

Observed names: C. Lumbala, Crispin wa Mbuyi Lumbala, Lumbala, C., Lumbala, Crispin
Observed institutions: Ministry of Public Health, Drugs for Neglected Diseases Initiative, University of Antwerp, University of Mbuji Mayi, Clinton Health Access Initiative, Université Officielle de Mbujimayi
ORCID: 0000-0001-8892-1610
Observed ORCID: 0000-0001-8892-1610
OpenAlex ID: A5023745735
Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial
2017 · Victor Kande Betu Ku Mesu, Wilfried Mutombo Kalonji, et al. · The Lancet · 286
Quantitative evaluation of the strategy to eliminate human African trypanosomiasis in the Democratic Republic of Congo
2015 · Kat S. Rock, Steve J. Torr, et al. · Parasites & Vectors · 85
PDF
Sensitivity and Specificity of a Prototype Rapid Diagnostic Test for the Detection of Trypanosoma brucei gambiense Infection: A Multi-centric Prospective Study
2016 · Sylvie Bisser, Crispin Lumbala, et al. · PLoS neglected tropical diseases · 82
PDF
Tsetse Control and the Elimination of Gambian Sleeping Sickness
2016 · Mike Lehane, Idriss Alfaroukh, et al. · PLoS neglected tropical diseases · 69
PDF
Should I Get Screened for Sleeping Sickness? A Qualitative Study in Kasai Province, Democratic Republic of Congo
2012 · Alain Mpanya, David Hendrickx, et al. · PLoS neglected tropical diseases · 67
PDF
Prospective evaluation of a rapid diagnostic test for Trypanosoma brucei gambiense infection developed using recombinant antigens
2018 · Crispin Lumbala, Sylvain Biéler, et al. · PLoS neglected tropical diseases · 62
PDF
Performance of Microscopy for the Diagnosis of Malaria and Human African Trypanosomiasis by Diagnostic Laboratories in the Democratic Republic of the Congo: Results of a Nation-Wide External Quality Assessment
2016 · Pierre Mukadi, Veerle Lejon, et al. · PLoS ONE · 61
PDF
Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study
2021 · Victor Kande Betu Ku Mesu, Wilfried Mutombo Kalonji, et al. · The Lancet Global Health · 58
PDF
Human African trypanosomiasis in the Democratic Republic of the Congo: disease distribution and risk
2015 · Crispin Lumbala, Pere P. Simarro, et al. · International Journal of Health Geographics · 54
PDF
Predicting the Impact of Intervention Strategies for Sleeping Sickness in Two High-Endemicity Health Zones of the Democratic Republic of Congo
2017 · Kat S. Rock, Steve J. Torr, et al. · PLoS neglected tropical diseases · 51
PDF
From Health Advice to Taboo: Community Perspectives on the Treatment of Sleeping Sickness in the Democratic Republic of Congo, a Qualitative Study
2015 · Alain Mpanya, David Hendrickx, et al. · PLoS neglected tropical diseases · 47
PDF
Integration of diagnosis and treatment of sleeping sickness in primary healthcare facilities in the Democratic Republic of the Congo
2014 · P. Mitashi, E. Hasker, et al. · Tropical Medicine & International Health · 34
Health care‐seeking behaviour and diagnostic delays for Human African Trypanosomiasis in the Democratic Republic of the Congo
2011 · E. Hasker, C. Lumbala, et al. · Tropical Medicine & International Health · 34
PDF
Performance of the SD BIOLINE® HAT rapid test in various diagnostic algorithms for gambiense human African trypanosomiasis in the Democratic Republic of the Congo
2017 · Crispin Lumbala, Paul R. Bessell, et al. · PLoS ONE · 31
PDF
Data-driven models to predict the elimination of sleeping sickness in former Equateur province of DRC
2017 · K.S. Rock, A. Pandey, et al. · Epidemics · 30
PDF
Cost-effectiveness of using a rapid diagnostic test to screen for human African trypanosomiasis in the Democratic Republic of the Congo
2018 · Paul R. Bessell, Crispin Lumbala, et al. · PLoS ONE · 26
PDF
Health Care Entrepreneurship in the Democratic Republic of the Congo: An Exploratory Study
2012 · Ngoyi K. Z. Bukonda, Masud Chand, et al. · Journal of African Business · 21
Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2–3 trial
2022 · Victor Kande Betu Kumesu, Wilfried Mutombo Kalonji, et al. · The Lancet Global Health · 20
Performance of ultra-sensitive malaria rapid diagnostic test to detect Plasmodium falciparum infection in pregnant women in Kinshasa, the Democratic Republic of the Congo
2023 · Japhet Kabalu Tshiongo, Flory Luzolo, et al. · Malaria Journal · 14
PDF
Forecasting Human African Trypanosomiasis Prevalences from Population Screening Data Using Continuous Time Models
2016 · Harwin de Vries, Albert P. M. Wagelmans, et al. · PLoS Computational Biology · 13
PDF
Integration of Human African Trypanosomiasis Control Activities into Primary Health Services in the Democratic Republic of the Congo: A Qualitative Study of Stakeholder Perceptions
2019 · Philippe Mulenga, Marleen Boelaert, et al. · American Journal of Tropical Medicine and Hygiene · 12
PDF
Integration of Human African Trypanosomiasis Control Activities into Primary Healthcare Services: A Scoping Review
2019 · Philippe Mulenga, Faustin Chenge, et al. · American Journal of Tropical Medicine and Hygiene · 11
PDF
Improved Detection of Sleeping Sickness Cases by LED Fluorescence Microscopy: Evidence from a Prospective Multi-Centric Study in the Democratic Republic of the Congo
2015 · Patrick Mitashi, Pascal Lutumba, et al. · Microscopy Research · 7
PDF
Development and implementation of a strategy for intensified screening for gambiense human African trypanosomiasis in Kongo Central province, DRC
2020 · Crispin Lumbala, Simon Kayembe, et al. · PLoS neglected tropical diseases · 6
PDF
Treatment outcomes for human African Trypanosomiasis in the Democratic Republic of the Congo: analysis of routine program data from the world’s largest sleeping sickness control program
2012 · E. Hasker, A. Mpanya, et al. · Tropical Medicine & International Health · 6
PDF
Works count: 46
Citation count: 1,196
H-index: 18
I10-index: 22
Year
Topic
Type